Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 7 | 2022 | 595 | 1.740 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 49 | 0.830 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 58 | 0.830 |
Why?
|
| Melanoma, Experimental | 2 | 2019 | 95 | 0.800 |
Why?
|
| Sphingosine | 2 | 2021 | 315 | 0.780 |
Why?
|
| Cellular Reprogramming | 2 | 2019 | 22 | 0.750 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 211 | 0.720 |
Why?
|
| Thioredoxins | 1 | 2019 | 26 | 0.690 |
Why?
|
| PPAR gamma | 1 | 2019 | 95 | 0.670 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.630 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 200 | 0.630 |
Why?
|
| Neoplasms | 7 | 2022 | 1660 | 0.610 |
Why?
|
| Glycine | 3 | 2013 | 89 | 0.600 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 499 | 0.600 |
Why?
|
| Organometallic Compounds | 3 | 2013 | 95 | 0.590 |
Why?
|
| Sirtuin 1 | 4 | 2020 | 47 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 756 | 0.550 |
Why?
|
| NAD | 3 | 2020 | 73 | 0.490 |
Why?
|
| Immunotherapy | 4 | 2022 | 212 | 0.490 |
Why?
|
| Macrophages | 3 | 2012 | 647 | 0.470 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 756 | 0.460 |
Why?
|
| Mitochondria | 5 | 2021 | 643 | 0.430 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 82 | 0.410 |
Why?
|
| Apoptosis | 5 | 2022 | 1640 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 2790 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 247 | 0.380 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2013 | 332 | 0.370 |
Why?
|
| Mice | 14 | 2022 | 8472 | 0.360 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 186 | 0.350 |
Why?
|
| Chelating Agents | 4 | 2013 | 47 | 0.340 |
Why?
|
| ADP-ribosyl Cyclase 1 | 2 | 2019 | 24 | 0.330 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2019 | 135 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 265 | 0.330 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 219 | 0.310 |
Why?
|
| Animals | 18 | 2022 | 20877 | 0.290 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2018 | 131 | 0.290 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 1849 | 0.280 |
Why?
|
| Glutathione | 4 | 2013 | 343 | 0.230 |
Why?
|
| Schiff Bases | 2 | 2013 | 12 | 0.220 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2022 | 3 | 0.220 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2022 | 18 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.220 |
Why?
|
| Carcinoma, Ehrlich Tumor | 2 | 2012 | 5 | 0.220 |
Why?
|
| L-Selectin | 2 | 2019 | 28 | 0.210 |
Why?
|
| Penicillium | 1 | 2021 | 3 | 0.210 |
Why?
|
| Air Pollution, Indoor | 1 | 2021 | 26 | 0.210 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 99 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1032 | 0.200 |
Why?
|
| Carrier State | 1 | 2021 | 39 | 0.200 |
Why?
|
| Acid Ceramidase | 1 | 2021 | 85 | 0.190 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2020 | 13 | 0.190 |
Why?
|
| Autophagy | 1 | 2022 | 207 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 54 | 0.180 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2019 | 16 | 0.180 |
Why?
|
| Interleukin-12 | 3 | 2022 | 75 | 0.180 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2019 | 18 | 0.180 |
Why?
|
| Metabolomics | 1 | 2019 | 28 | 0.180 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2019 | 63 | 0.170 |
Why?
|
| Aflatoxin M1 | 1 | 2018 | 1 | 0.170 |
Why?
|
| Trichothecenes | 1 | 2018 | 2 | 0.170 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2018 | 33 | 0.170 |
Why?
|
| Thiazolidines | 1 | 2018 | 23 | 0.170 |
Why?
|
| Dronabinol | 1 | 2019 | 84 | 0.170 |
Why?
|
| Food Contamination | 1 | 2018 | 56 | 0.160 |
Why?
|
| Goblet Cells | 1 | 2018 | 9 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2018 | 231 | 0.160 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2018 | 26 | 0.160 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 118 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2021 | 337 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 86 | 0.160 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 184 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 87 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 304 | 0.160 |
Why?
|
| Ceramides | 1 | 2021 | 578 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 199 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 742 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 370 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 397 | 0.150 |
Why?
|
| Humans | 16 | 2022 | 68525 | 0.150 |
Why?
|
| Antioxidants | 1 | 2019 | 304 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 329 | 0.140 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 163 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 2 | 2013 | 56 | 0.140 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 121 | 0.140 |
Why?
|
| Phenotype | 1 | 2019 | 946 | 0.140 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 79 | 0.140 |
Why?
|
| Th17 Cells | 2 | 2017 | 116 | 0.140 |
Why?
|
| Interferon-gamma | 2 | 2016 | 241 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2021 | 2688 | 0.130 |
Why?
|
| Aging | 1 | 2021 | 911 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 1070 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2012 | 791 | 0.110 |
Why?
|
| Melanoma | 1 | 2016 | 335 | 0.110 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 50 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2012 | 57 | 0.100 |
Why?
|
| Acetophenones | 1 | 2011 | 12 | 0.100 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2011 | 24 | 0.100 |
Why?
|
| Female | 7 | 2021 | 38015 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 1026 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2022 | 65 | 0.090 |
Why?
|
| Iron Chelating Agents | 1 | 2010 | 31 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2011 | 231 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 384 | 0.090 |
Why?
|
| Copper | 1 | 2009 | 149 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 226 | 0.080 |
Why?
|
| Biomarkers | 2 | 2021 | 1593 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 284 | 0.060 |
Why?
|
| Th1 Cells | 2 | 2017 | 101 | 0.060 |
Why?
|
| Necrosis | 2 | 2016 | 239 | 0.060 |
Why?
|
| Male | 3 | 2021 | 37281 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2016 | 489 | 0.060 |
Why?
|
| Acetyl Coenzyme A | 1 | 2022 | 10 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1745 | 0.050 |
Why?
|
| Aspergillus | 1 | 2021 | 8 | 0.050 |
Why?
|
| Air Microbiology | 1 | 2021 | 8 | 0.050 |
Why?
|
| Floods | 1 | 2021 | 6 | 0.050 |
Why?
|
| Fungi | 1 | 2021 | 27 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1034 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2022 | 87 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2022 | 126 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2011 | 79 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 183 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 196 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 215 | 0.050 |
Why?
|
| Caspase 3 | 2 | 2011 | 233 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2019 | 41 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 32 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 346 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2550 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2019 | 20 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 89 | 0.040 |
Why?
|
| Feces | 1 | 2019 | 88 | 0.040 |
Why?
|
| Histones | 1 | 2019 | 111 | 0.040 |
Why?
|
| Infant Food | 1 | 2018 | 16 | 0.040 |
Why?
|
| India | 1 | 2018 | 41 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 94 | 0.040 |
Why?
|
| Carbazoles | 1 | 2018 | 46 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 222 | 0.040 |
Why?
|
| Streptomycin | 1 | 2018 | 12 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 242 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 149 | 0.040 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2018 | 72 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1663 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Vancomycin | 1 | 2018 | 60 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 241 | 0.040 |
Why?
|
| Glutamine | 1 | 2017 | 45 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 532 | 0.040 |
Why?
|
| Neomycin | 1 | 2018 | 56 | 0.040 |
Why?
|
| Colon | 1 | 2018 | 168 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1609 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 30 | 0.040 |
Why?
|
| Heterografts | 1 | 2016 | 70 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 100 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 331 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1037 | 0.030 |
Why?
|
| Coordination Complexes | 1 | 2013 | 16 | 0.030 |
Why?
|
| K562 Cells | 1 | 2013 | 44 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 65 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 63 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 111 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2013 | 237 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 420 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2012 | 62 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 326 | 0.030 |
Why?
|
| Cell Communication | 1 | 2012 | 116 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 2891 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 72 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 3185 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2011 | 282 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 852 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2010 | 25 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 39 | 0.020 |
Why?
|
| Calpain | 1 | 2011 | 205 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2010 | 144 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 397 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 901 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2798 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 32 | 0.020 |
Why?
|
| Iron | 1 | 2011 | 197 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 63 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 124 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2009 | 144 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 306 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8903 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2673 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 929 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7028 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1173 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14842 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 21119 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 21375 | 0.010 |
Why?
|